论文部分内容阅读
为研究未加选择的系统性红斑狼疮(SLE)病人血清中抗心脂质抗体的发生率,作者用酶联免疫吸附试验,对59例未经挑选的SLE病人血清中的抗心脂质抗体进行了测定.并对156份献血员和健康实验室工作人员的血清作了对照测定.结果发现32例(54.2%)SLE病人血清中抗心脂质抗体浓度增高,其中28例含有IgG类抗心脂质抗体,4例含IgM类抗心脂质抗体.28例含IgG类抗心脂质抗体的病人,此抗体水平>3Au,其中18例病人抗体水平≥5Au,5例病人≥10Au.并发现血清抗心脂质抗体量的增高和临床症状(诸如血小板减少、血栓形成)之间无明显关系.多数病人的血
In order to study the prevalence of anti-lipid-lipid antibodies in the serum of unselected patients with systemic lupus erythematosus (SLE), the authors used enzyme-linked immunosorbent assay (ELISA) to detect the presence of anti-lipid antibodies in serum of 59 unselected SLE patients The serum levels of 156 blood donors and health laboratory workers were measured and the results showed that the serum concentrations of anti-lipids increased in 32 (54.2%) SLE patients and 28 of them contained anti-IgG antibodies In 4 patients with IgM-containing anti-lipids, 28 patients with IgG-containing anti-lipids were at 3Au level, 18 patients had antibody levels ≥5Au and 5 patients ≥10Au. And found no significant relationship between elevated serum anti-lipid-lipid antibodies and clinical symptoms such as thrombocytopenia and thrombosis.Most patient’s blood